Unibest

Pharmaceutical intermediates

Avatrombopag Maleate Intermediates

4 pharmaceutical intermediates for Avatrombopag Maleate. Indication: Idiopathic Thrombocytopenic Purpura (ITP); Thrombocytopenia.

提交项目All intermediates

About Avatrombopag Maleate

Originator
Astellas Pharma Inc.
Indication
Idiopathic Thrombocytopenic Purpura (ITP); Thrombocytopenia
Approved Date
05/21/2018
DS/DP
07/28/2027

Available intermediates

4 intermediates currently listed for Avatrombopag Maleate. Request specifications, documentation or a quotation for any item below.

Avatrombopag Maleate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-(4-chloro-2-thienyl)-2-ThiazolaMine570407-10-2//
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine570407-42-0//
1-Cyclohexylpiperazine17766-28-8//
5,6-Dichloronicotinic acid41667-95-2//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Avatrombopag Maleate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →